Showing results (171-180 of 358) with videos related to
Sort By:
Pageof 36
Metabolism: Clinical and Experimental|May 19, 2012
Snail, a transcriptional regulator, represses adiponectin expression by directly binding to an E-box motif in the promoterYoung Mi Park, Yong-ho Lee, Soo Hyun Kim, et al.Plos One|December 11, 2012
Human monoclonal antibodies against glucagon receptor improve glucose homeostasis by suppression of hepatic glucose output in diet-induced obese miceWook-Dong Kim, Yong-ho Lee, Min-Hee Kim, et al.Frontiers in Endocrinology|March 10, 2023
Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetesSejeong Lee, Jaehyun Bae, Doo Ri Jo, et al.Journal of Korean Medical Science|December 4, 2016
Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to ResponsivenessYong Ho Lee, Jae Hyeon Kim, So Ra Kim, et al.Medicine|July 12, 2016
Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetesSo Ra Kim, Yong-Ho Lee, Sang-Guk Lee, et al.Journal of Clinical Medicine|March 17, 2025
Potential Impact of Choline Alphoscerate on Depressive Symptoms in Association with Insulin Resistance in Elderly Patients with Type 2 DiabetesInkuk Lee, Minyoung Lee, Min Heui Yu, et al.Frontiers in Endocrinology|August 4, 2018
Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes MellitusEugene Han, Eugene Shin, Gyuri Kim, et al.Frontiers in Endocrinology|January 23, 2024
Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetesSejeong Lee, Jaehyun Bae, Seung Up Kim, et al.Yonsei Medical Journal|September 6, 2016
Repolarization Heterogeneity of Magnetocardiography Predicts Long-Term Prognosis in Patients with Acute Myocardial InfarctionWoo Dae Bang, Kiwoong Kim, Yong Ho Lee, et al.Diabetes & Metabolism Journal|January 29, 2019
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 InhibitorsJi Yeon Lee, Yongin Cho, Minyoung Lee, et al.Pageof 36